VBIO
Valion Bio, Inc.
Price Chart
No historical data available
Latest Quote
$3.57
+0.55 (+18.11%)
Current Price
| Previous Close | $3.02 |
| Open | $2.80 |
| Day High | $3.85 |
| Day Low | $2.80 |
| Volume | 631,528 |
Stock Information
| Shares Outstanding | 888K |
| Total Debt | $17.41M |
| Cash Equivalents | $2.11M |
| Revenue | $-86K |
| Net Income | $-18.71M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $3.17M |
| EPS (TTM) | $-184.45 |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About Valion Bio, Inc.
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
đ° Latest News
No news articles available at the moment. Check back later for updates on VBIO.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $1,176,000 | $1,840,000 |
| Operating Revenue | $0 | $0 | $1,176,000 | $1,840,000 |
| Reconciled Cost Of Revenue | - | $778,000 | $889,000 | $1,541,000 |
| Cost Of Revenue | - | $778,000 | $889,000 | $1,541,000 |
| Expenses | ||||
| Interest Expense | $146,000 | $0 | - | - |
| Total Expenses | $7,898,000 | $4,476,000 | $9,421,000 | $11,938,000 |
| Other Income Expense | $28,000 | - | - | - |
| Net Non Operating Interest Income Expense | $-123,000 | $6,000 | $1,000 | $2,000 |
| Interest Expense Non Operating | $146,000 | $0 | - | - |
| Operating Expense | $7,898,000 | $4,476,000 | $8,532,000 | $10,397,000 |
| General And Administrative Expense | $4,767,000 | $3,163,000 | $4,752,000 | $5,875,000 |
| Selling And Marketing Expense | - | $1,187,000 | $2,125,000 | $2,792,000 |
| Total Other Finance Cost | - | - | - | $-2,000 |
| Other Non Operating Income Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-7,993,000 | $-4,470,000 | $-8,244,000 | $-10,096,000 |
| Net Interest Income | $-123,000 | $6,000 | $1,000 | $2,000 |
| Interest Income | $23,000 | $6,000 | $1,000 | $2,000 |
| Normalized Income | $-8,021,000 | $-4,470,000 | $-8,244,000 | $-10,096,000 |
| Net Income From Continuing And Discontinued Operation | $-8,878,000 | $-5,655,000 | $-8,244,000 | $-10,096,000 |
| Total Operating Income As Reported | $-7,898,000 | $-4,476,000 | $-8,245,000 | $-10,098,000 |
| Net Income Common Stockholders | $-8,878,000 | $-5,655,000 | $-8,244,000 | $-10,096,000 |
| Net Income | $-8,878,000 | $-5,655,000 | $-8,244,000 | $-10,096,000 |
| Net Income Including Noncontrolling Interests | $-8,878,000 | $-5,655,000 | $-8,244,000 | $-10,096,000 |
| Net Income Discontinuous Operations | $-885,000 | $-1,185,000 | - | - |
| Net Income Continuous Operations | $-7,993,000 | $-4,470,000 | $-8,244,000 | $-10,096,000 |
| Pretax Income | $-7,993,000 | $-4,470,000 | $-8,244,000 | $-10,096,000 |
| Interest Income Non Operating | $23,000 | $6,000 | $1,000 | $2,000 |
| Operating Income | $-7,898,000 | $-4,476,000 | $-8,245,000 | $-10,098,000 |
| Gross Profit | - | $2,000 | $287,000 | $299,000 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-7.84 | $-19.68 | $-176.80 | $-1768.00 |
| Basic EPS | $-7.84 | $-19.68 | $-176.80 | $-1768.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-7,870,000 | $-4,118,000 | $-8,063,000 | $-9,924,000 |
| Total Unusual Items | $28,000 | - | - | $0 |
| Total Unusual Items Excluding Goodwill | $28,000 | - | - | $0 |
| Reconciled Depreciation | $5,000 | $352,000 | $182,000 | $174,000 |
| EBITDA (Bullshit earnings) | $-7,842,000 | $-4,118,000 | $-8,063,000 | $-9,924,000 |
| EBIT | $-7,847,000 | $-4,470,000 | $-8,245,000 | $-10,098,000 |
| Diluted Average Shares | $1,155,531 | $287,370 | $46,650 | $5,689 |
| Basic Average Shares | $1,155,531 | $287,370 | $46,650 | $5,689 |
| Diluted NI Availto Com Stockholders | $-8,878,000 | $-5,655,000 | $-8,244,000 | $-10,096,000 |
| Gain On Sale Of Security | $28,000 | - | - | - |
| Research And Development | $3,131,000 | $1,313,000 | $1,655,000 | $1,730,000 |
| Selling General And Administration | $4,767,000 | $3,163,000 | $6,877,000 | $8,667,000 |
| Other Gand A | $4,767,000 | $3,163,000 | $4,752,000 | $5,875,000 |
| Tax Provision | - | - | - | - |
| Other Special Charges | - | - | - | - |
Fetched: 2026-08-10
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $14,554,000 | $2,535,000 | $3,580,000 | $3,630,000 |
| Total Assets | $31,607,000 | $2,807,000 | $5,157,000 | $5,875,000 |
| Total Non Current Assets | $18,601,000 | $168,000 | $505,000 | $569,000 |
| Other Non Current Assets | $124,000 | $117,000 | $34,000 | $34,000 |
| Non Current Deferred Assets | $136,000 | $49,000 | $0 | - |
| Goodwill And Other Intangible Assets | $2,243,000 | $0 | - | - |
| Other Intangible Assets | $2,243,000 | - | - | - |
| Current Assets | $13,006,000 | $2,639,000 | $4,652,000 | $5,306,000 |
| Other Current Assets | $346,000 | $240,000 | $327,000 | $235,000 |
| Assets Held For Sale Current | $15,000 | $397,000 | - | - |
| Cash Cash Equivalents And Short Term Investments | $12,645,000 | $2,002,000 | $3,395,000 | $3,517,000 |
| Cash And Cash Equivalents | $12,645,000 | $2,002,000 | $3,395,000 | $3,517,000 |
| Inventory | - | $319,000 | $756,000 | $863,000 |
| Receivables | - | $69,000 | $174,000 | $107,000 |
| Accounts Receivable | - | $69,000 | $174,000 | $107,000 |
| Current Deferred Assets | - | - | $0 | $584,000 |
| Allowance For Doubtful Accounts Receivable | - | - | - | $0 |
| Gross Accounts Receivable | - | - | - | $88,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $6,454,000 | $0 | $369,000 | $530,000 |
| Long Term Debt And Capital Lease Obligation | $6,454,000 | $0 | $176,000 | $367,000 |
| Long Term Debt | $6,454,000 | - | - | - |
| Current Debt And Capital Lease Obligation | - | - | $193,000 | $163,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $14,810,000 | $272,000 | $1,577,000 | $2,245,000 |
| Total Non Current Liabilities Net Minority Interest | $14,164,000 | $0 | $176,000 | $367,000 |
| Other Non Current Liabilities | $48,000 | - | - | - |
| Liabilities Heldfor Sale Non Current | $0 | $0 | - | - |
| Derivative Product Liabilities | $292,000 | $0 | - | - |
| Current Liabilities | $646,000 | $272,000 | $1,401,000 | $1,878,000 |
| Other Current Liabilities | $6,000 | $15,000 | - | - |
| Payables And Accrued Expenses | $640,000 | $257,000 | $1,208,000 | $1,715,000 |
| Payables | $444,000 | $125,000 | $873,000 | $1,323,000 |
| Total Tax Payable | $180,000 | $0 | $160,000 | - |
| Accounts Payable | $264,000 | $125,000 | $713,000 | $1,323,000 |
| Equity | ||||
| Common Stock Equity | $16,797,000 | $2,535,000 | $3,580,000 | $3,630,000 |
| Total Equity Gross Minority Interest | $16,797,000 | $2,535,000 | $3,580,000 | $3,630,000 |
| Stockholders Equity | $16,797,000 | $2,535,000 | $3,580,000 | $3,630,000 |
| Retained Earnings | $-52,597,000 | $-43,541,000 | $-37,886,000 | $-29,642,000 |
| Preferred Securities Outside Stock Equity | $7,370,000 | $0 | - | - |
| Other | ||||
| Ordinary Shares Number | $2,525,778 | $556,977 | $86,240 | $5,692 |
| Share Issued | $2,525,778 | $556,977 | $86,240 | $5,692 |
| Tangible Book Value | $14,554,000 | $2,535,000 | $3,580,000 | $3,630,000 |
| Invested Capital | $23,251,000 | $2,535,000 | $3,580,000 | $3,630,000 |
| Working Capital | $12,360,000 | $2,367,000 | $3,251,000 | $3,428,000 |
| Total Capitalization | $23,251,000 | $2,535,000 | $3,580,000 | $3,630,000 |
| Additional Paid In Capital | $69,392,000 | $46,075,000 | $41,466,000 | $33,272,000 |
| Capital Stock | $2,000 | $1,000 | $0 | $0 |
| Common Stock | $2,000 | $1,000 | $0 | $0 |
| Current Accrued Expenses | $196,000 | $132,000 | $335,000 | $392,000 |
| Net PPE | $16,098,000 | $2,000 | $471,000 | $535,000 |
| Accumulated Depreciation | $-15,000 | $-40,000 | $-37,000 | $-29,000 |
| Gross PPE | $16,113,000 | $42,000 | $508,000 | $564,000 |
| Machinery Furniture Equipment | $12,656,000 | $11,000 | $11,000 | $11,000 |
| Buildings And Improvements | $3,457,000 | $0 | $349,000 | $523,000 |
| Properties | $0 | $0 | $0 | $0 |
| Capital Lease Obligations | - | $0 | $369,000 | $530,000 |
| Preferred Stock | - | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | - | $0 | $176,000 | $367,000 |
| Current Capital Lease Obligation | - | $0 | $193,000 | $163,000 |
| Other Properties | - | $31,000 | $148,000 | $30,000 |
| Inventories Adjustments Allowances | - | $-338,000 | $-32,000 | $0 |
| Finished Goods | - | $192,000 | $36,000 | $116,000 |
| Work In Process | - | $5,000 | $0 | $23,000 |
| Raw Materials | - | $460,000 | $752,000 | $724,000 |
| Treasury Shares Number | - | - | $0 | - |
Fetched: 2026-08-10
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-7,580,000 | $-5,725,000 | $-8,629,000 | $-8,930,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-6,999,000 | $-5,725,000 | $-8,511,000 | $-8,919,000 |
| Cash From Discontinued Operating Activities | $-380,000 | $-643,000 | - | - |
| Cash Flow From Continuing Operating Activities | $-6,619,000 | $-5,082,000 | $-8,511,000 | $-8,919,000 |
| Operating Gains Losses | $-28,000 | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-581,000 | - | $-118,000 | $-11,000 |
| Investing Cash Flow | $-705,000 | $0 | $-118,000 | $-11,000 |
| Cash Flow From Continuing Investing Activities | $-705,000 | $0 | $-118,000 | $-11,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $18,546,000 | $4,381,000 | $8,507,000 | $0 |
| Financing Cash Flow | $18,347,000 | $4,332,000 | $8,507,000 | $-528,000 |
| Cash Flow From Continuing Financing Activities | $18,347,000 | $4,332,000 | $8,507,000 | $-528,000 |
| Net Other Financing Charges | $-308,000 | $-49,000 | - | $-584,000 |
| Net Preferred Stock Issuance | $16,209,000 | $0 | - | - |
| Preferred Stock Issuance | $16,209,000 | $0 | - | - |
| Net Common Stock Issuance | $2,337,000 | $4,381,000 | $8,507,000 | $0 |
| Common Stock Issuance | $2,337,000 | $4,381,000 | $8,507,000 | $0 |
| Other | ||||
| End Cash Position | $12,645,000 | $2,002,000 | $3,395,000 | $3,517,000 |
| Beginning Cash Position | $2,002,000 | $3,395,000 | $3,517,000 | $12,975,000 |
| Changes In Cash | $10,643,000 | $-1,393,000 | $-122,000 | $-9,458,000 |
| Proceeds From Stock Option Exercised | $109,000 | $0 | $0 | $56,000 |
| Net Investment Purchase And Sale | $-124,000 | $0 | - | - |
| Purchase Of Investment | $-124,000 | $0 | - | - |
| Net Intangibles Purchase And Sale | $-543,000 | $0 | - | - |
| Purchase Of Intangibles | $-543,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-38,000 | $0 | $-118,000 | $-11,000 |
| Purchase Of PPE | $-38,000 | $0 | $-118,000 | $-11,000 |
| Change In Working Capital | $452,000 | $-1,193,000 | $-752,000 | $605,000 |
| Change In Other Current Liabilities | $0 | $-369,000 | $-161,000 | $-178,000 |
| Change In Other Current Assets | $0 | $34,000 | $0 | $15,000 |
| Change In Payables And Accrued Expense | $374,000 | $-936,000 | $-507,000 | $643,000 |
| Change In Accrued Expense | $235,000 | $-348,000 | $103,000 | $109,000 |
| Change In Payable | $139,000 | $-588,000 | $-610,000 | $534,000 |
| Change In Account Payable | $139,000 | $-588,000 | $-610,000 | $534,000 |
| Change In Prepaid Assets | $78,000 | $78,000 | $-92,000 | $558,000 |
| Other Non Cash Items | $238,000 | - | - | - |
| Stock Based Compensation | $564,000 | $229,000 | $271,000 | $398,000 |
| Asset Impairment Charge | $143,000 | $0 | - | - |
| Depreciation Amortization Depletion | $5,000 | $352,000 | $182,000 | $174,000 |
| Depreciation And Amortization | $5,000 | $352,000 | $182,000 | $174,000 |
| Depreciation | $5,000 | $352,000 | $182,000 | $174,000 |
| Gain Loss On Investment Securities | $-28,000 | - | - | - |
| Net Income From Continuing Operations | $-7,993,000 | $-4,470,000 | $-8,244,000 | $-10,096,000 |
| Change In Inventory | - | $83,000 | $75,000 | $-434,000 |
| Change In Receivables | - | $105,000 | $-67,000 | $1,000 |
| Changes In Account Receivables | - | $105,000 | $-67,000 | $1,000 |
| Provisionand Write Offof Assets | - | $354,000 | $32,000 | $0 |
| Repayment Of Debt | - | - | - | $0 |
| Issuance Of Debt | - | - | - | $0 |
| Net Issuance Payments Of Debt | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Interest Paid Supplemental Data | - | - | - | - |
| Income Tax Paid Supplemental Data | - | - | - | - |
Fetched: 2026-08-10